Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ZYXI Stock Forecast 2025-2026
$2.40
Current Price
$69.40M
Market Cap
Buy 1
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to ZYXI Price Targets
+233.3%
To High Target of $8.00
+150.0%
To Median Target of $6.00
+66.7%
To Low Target of $4.00
ZYXI Price Momentum
-3.2%
1 Week Change
-4.8%
1 Month Change
-77.2%
1 Year Change
-70.0%
Year-to-Date Change
-77.4%
From 52W High of $10.62
+44.6%
From 52W Low of $1.66
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Zynex (ZYXI) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ZYXI and similar high-potential opportunities.
Latest ZYXI Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, ZYXI has a neutral consensus with a median price target of $6.00 (ranging from $4.00 to $8.00). The overall analyst rating is Buy (6.7/10). Currently trading at $2.40, the median forecast implies a 150.0% upside. This outlook is supported by 1 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Yi Chen at HC Wainwright & Co., projecting a 233.3% upside. Conversely, the most conservative target is provided by Shagun Singh at RBC Capital, suggesting a 66.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ZYXI Analyst Ratings
1
Buy
2
Hold
0
Sell
ZYXI Price Target Range
Low
$4.00
Average
$6.00
High
$8.00
Current: $2.40
Latest ZYXI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ZYXI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 30, 2025 | HC Wainwright & Co. | Yi Chen | Buy | Maintains | $8.00 |
| Apr 30, 2025 | RBC Capital | Shagun Singh | Sector Perform | Maintains | $4.00 |
| Mar 12, 2025 | HC Wainwright & Co. | Yi Chen | Buy | Maintains | $15.00 |
| Mar 12, 2025 | RBC Capital | Shagun Singh | Sector Perform | Downgrade | $5.50 |
| Mar 12, 2025 | Ladenburg Thalmann | Jeffrey Cohen | Neutral | Downgrade | $0.00 |
| Dec 6, 2024 | HC Wainwright & Co. | Yi Chen | Buy | Reiterates | $17.00 |
| Oct 25, 2024 | HC Wainwright & Co. | Yi Chen | Buy | Maintains | $17.00 |
| Oct 8, 2024 | RBC Capital | Shagun Singh | Outperform | Maintains | $11.00 |
| Sep 4, 2024 | HC Wainwright & Co. | Yi Chen | Buy | Reiterates | $16.00 |
| Jul 26, 2024 | RBC Capital | Shagun Singh | Outperform | Maintains | $12.00 |
| Jul 26, 2024 | HC Wainwright & Co. | Yi Chen | Buy | Maintains | $16.00 |
| Jun 14, 2024 | RBC Capital | Shagun Singh | Outperform | Reiterates | $15.00 |
| May 1, 2024 | HC Wainwright & Co. | Yi Chen | Buy | Reiterates | $21.00 |
| Mar 1, 2024 | HC Wainwright & Co. | Yi Chen | Buy | Maintains | $21.00 |
| Mar 1, 2024 | RBC Capital | Shagun Singh | Outperform | Maintains | $15.00 |
| Oct 16, 2023 | RBC Capital | Shagun Singh | Outperform | Initiates | $13.00 |
| Apr 28, 2023 | HC Wainwright & Co. | Yi Chen | Buy | Reiterates | $20.00 |
| Apr 12, 2023 | HC Wainwright & Co. | Yi Chen | Buy | Reiterates | $20.00 |
| Mar 28, 2023 | Ladenburg Thalmann | Jeffrey Cohen | Buy | Maintains | $28.00 |
| Mar 14, 2023 | HC Wainwright & Co. | Yi Chen | Buy | Reiterates | $20.00 |
Zynex Inc. (ZYXI) Competitors
The following stocks are similar to Zynex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Zynex Inc. (ZYXI) Financial Data
Zynex Inc. has a market capitalization of $69.40M with a P/E ratio of 25.3x. The company generates $172.40M in trailing twelve-month revenue with a -4.3% profit margin.
Revenue growth is -42.9% quarter-over-quarter, while maintaining an operating margin of -49.3% and return on equity of -27.5%.
Valuation Metrics
Market Cap
$69.40M
Enterprise Value
$117.83M
P/E Ratio
25.3x
PEG Ratio
4.8x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
-42.9%
Gross Margin
+68.5%
Operating Margin
-49.3%
Net Margin
-4.3%
EPS Growth
-42.9%
Financial Health
Cash/Price Ratio
+32.9%
Current Ratio
3.5x
Debt/Equity
351.6x
ROE
-27.5%
ROA
-4.1%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Zynex Inc. (ZYXI) Business Model
About Zynex Inc.
What They Do
Manufacturer of non-invasive medical devices.
Business Model
Zynex Inc. generates revenue by developing and marketing non-invasive medical devices that focus on pain management, rehabilitation, and monitoring. Its flagship products, such as the NexWave device, are sold to hospitals, clinics, and healthcare providers, targeting a growing demand for alternative pain solutions.
Additional Information
Founded in 1996 and based in Englewood, Colorado, Zynex Inc. emphasizes improving patient quality of life while minimizing pharmaceutical reliance. The company is positioned within the healthcare industry to meet the increasing need for personalized healthcare management solutions.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
1,000
CEO
Mr. Thomas Sandgaard
Country
United States
IPO Year
2003
Website
www.zynex.comZynex Inc. (ZYXI) Latest News & Analysis
Latest News
Quick Summary
A class action lawsuit has been filed against Zynex, Inc. (NASDAQ: ZYXI) and some of its officers, as announced by the law firm Bronstein, Gewirtz & Grossman, LLC.
Why It Matters
The class action lawsuit against Zynex, Inc. may lead to financial liabilities, regulatory scrutiny, and potential reputational damage, impacting stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Levi & Korsinsky, LLP has announced a class action securities lawsuit against Zynex, Inc. (NASDAQ: ZYXI), notifying investors of the legal proceedings as of May 19, 2025.
Why It Matters
A class action lawsuit against Zynex, Inc. could lead to financial liabilities, reputational damage, and stock volatility, impacting investor confidence and share prices.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A class action lawsuit has been filed against Zynex, Inc. (NASDAQ: ZYXI). Investors can contact Pomerantz LLP for more information.
Why It Matters
A class action lawsuit against Zynex may indicate potential legal liabilities and financial risks, which could negatively impact the company's stock performance and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Zynex, Inc. (NASDAQ: ZYXI) investors who experienced losses may explore recovery options under federal securities laws. More information is available via a linked submission form.
Why It Matters
Potential legal actions against Zynex, Inc. could impact investor sentiment, affecting stock prices and recovery prospects for those who suffered losses.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Investors in Zynex, Inc. (NASDAQ: ZYXI) who experienced losses may explore potential recovery options under federal securities laws. More information is available through the provided link.
Why It Matters
The news indicates potential legal actions against Zynex, Inc., which could affect the company's stock price and investor sentiment, prompting concerns about financial stability and future performance.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Investors in Zynex, Inc. (NASDAQ: ZYXI) who experienced losses may explore potential recovery options under federal securities laws. More details are available through a provided link.
Why It Matters
Legal action regarding Zynex, Inc. could signal potential financial liabilities and impacts on stock performance, influencing investor sentiment and decisions.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About ZYXI Stock
What is Zynex Inc.'s (ZYXI) stock forecast for 2025?
Based on our analysis of 7 Wall Street analysts, Zynex Inc. (ZYXI) has a median price target of $6.00. The highest price target is $8.00 and the lowest is $4.00.
Is ZYXI stock a good investment in 2025?
According to current analyst ratings, ZYXI has 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.40. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ZYXI stock?
Wall Street analysts predict ZYXI stock could reach $6.00 in the next 12 months. This represents a 150.0% increase from the current price of $2.40. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Zynex Inc.'s business model?
Zynex Inc. generates revenue by developing and marketing non-invasive medical devices that focus on pain management, rehabilitation, and monitoring. Its flagship products, such as the NexWave device, are sold to hospitals, clinics, and healthcare providers, targeting a growing demand for alternative pain solutions.
What is the highest forecasted price for ZYXI Zynex Inc.?
The highest price target for ZYXI is $8.00 from Yi Chen at HC Wainwright & Co., which represents a 233.3% increase from the current price of $2.40.
What is the lowest forecasted price for ZYXI Zynex Inc.?
The lowest price target for ZYXI is $4.00 from Shagun Singh at RBC Capital, which represents a 66.7% increase from the current price of $2.40.
What is the overall ZYXI consensus from analysts for Zynex Inc.?
The overall analyst consensus for ZYXI is neutral. Out of 7 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $6.00.
How accurate are ZYXI stock price projections?
Stock price projections, including those for Zynex Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 24, 2025 4:52 AM UTC